Radboudumc gives first-ever experimental T-cell therapy to pancreatic cancer patient

For the first time in the world, Radboudumc has treated a patient with pancreatic cancer using a new experimental immunotherapy that genetically modifies the patient’s own immune cells to recognize

By 88560